These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35703076)

  • 1. [The antiviral targeting potential of viroporins].
    Sund JD; Bollerup S; Glamann JB; Vinten CA; Jensen LR; Toft-Bethelsen TL; Bentzen BH; Kledal TN; Weis N; Rosenkilde M
    Ugeskr Laeger; 2022 Jun; 184(24):. PubMed ID: 35703076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.
    Toft-Bertelsen TL; Jeppesen MG; Tzortzini E; Xue K; Giller K; Becker S; Mujezinovic A; Bentzen BH; B Andreas L; Kolocouris A; Kledal TN; Rosenkilde MM
    Commun Biol; 2021 Dec; 4(1):1347. PubMed ID: 34853399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2.
    Breitinger U; Farag NS; Sticht H; Breitinger HG
    Int J Biochem Cell Biol; 2022 Apr; 145():106185. PubMed ID: 35219876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro.
    Zhou Y; Gammeltoft KA; Galli A; Offersgaard A; Fahnøe U; Ramirez S; Bukh J; Gottwein JM
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.
    Gargan S; Stevenson NJ
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prominent Efficacy of Amantadine against Human Borna Disease Virus Infection In Vitro and In Vivo. Comment on Fink et al. Amantadine Inhibits SARS-CoV-2 In Vitro.
    Bode L; Dietrich DE; Spannhuth CW; Ludwig H
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Channel activity of SARS-CoV-2 viroporin ORF3a inhibited by adamantanes and phenolic plant metabolites.
    Fam MS; Sedky CA; Turky NO; Breitinger HG; Breitinger U
    Sci Rep; 2023 Apr; 13(1):5328. PubMed ID: 37005439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
    Mandour YM; Breitinger U; Ma C; Wang J; Boeckler FM; Breitinger HG; Zlotos DP
    Drug Des Devel Ther; 2018; 12():1019-1031. PubMed ID: 29750015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine as a drug to mitigate the effects of COVID-19.
    Abreu GEA; Aguilar MEH; Covarrubias DH; Durán FR
    Med Hypotheses; 2020 Jul; 140():109755. PubMed ID: 32361100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2.
    Breitinger U; Sedky CA; Sticht H; Breitinger HG
    Virol J; 2023 Jul; 20(1):142. PubMed ID: 37422646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors.
    Cao Y; Yang R; Lee I; Zhang W; Sun J; Wang W; Meng X
    Protein Sci; 2021 Jun; 30(6):1114-1130. PubMed ID: 33813796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors.
    Breitinger U; Ali NKM; Sticht H; Breitinger HG
    Front Microbiol; 2021; 12():692423. PubMed ID: 34305855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor.
    Dey D; Borkotoky S; Banerjee M
    Comput Biol Med; 2020 Dec; 127():104063. PubMed ID: 33126128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The minimalist architectures of viroporins and their therapeutic implications.
    OuYang B; Chou JJ
    Biochim Biophys Acta; 2014 Apr; 1838(4):1058-67. PubMed ID: 24055819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viroporins: structure, function and potential as antiviral targets.
    Scott C; Griffin S
    J Gen Virol; 2015 Aug; 96(8):2000-2027. PubMed ID: 26023149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How many SARS-CoV-2 "viroporins" are really ion channels?
    Harrison NL; Abbott GW; Gentzsch M; Aleksandrov A; Moroni A; Thiel G; Grant S; Nichols CG; Lester HA; Hartel A; Shepard K; Garcia DC; Yazawa M
    Commun Biol; 2022 Aug; 5(1):859. PubMed ID: 36008538
    [No Abstract]   [Full Text] [Related]  

  • 17. Amantadine Treatment for People with COVID-19.
    Araújo R; Aranda-Martínez JD; Aranda-Abreu GE
    Arch Med Res; 2020 Oct; 51(7):739-740. PubMed ID: 32571606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels?
    Toft-Bertelsen TL; Jeppesen MG; Landbrug A; Mujezinovic A; Bentzen BH; Kledal TN; Rosenkilde MM
    Commun Biol; 2022 Aug; 5(1):860. PubMed ID: 36008476
    [No Abstract]   [Full Text] [Related]  

  • 19. Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2.
    Cortés-Borra A; Aranda-Abreu GE
    Pharmacol Rep; 2021 Jun; 73(3):962-965. PubMed ID: 33604795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Gradient pH-Sensitive Polymer-Based Antiviral Strategy via Viroporin-Induced Membrane Acidification.
    Sun Y; Gong L; Yin Y; Zhang L; Sun Q; Feng K; Cui Y; Zhang Q; Zhang X; Deng X; You F; Lu D; Lin Z
    Adv Mater; 2022 May; 34(18):e2109580. PubMed ID: 35229371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.